Home

News

 

Europe needs to tackle the burden for patients and society caused by blood cancers
PRESS RELEASE: New HARMONY CML Research Project will study the role of genetic aberrations in the disease course of Chronic Myeloid Leukemia.
PRESS RELEASE: HARMONY presents new insights in Chronic Lymphocytic Leukemia at EHA2021
IMI Impact on data series: Applying big data to advance research
ICT&health publishes news article about the HARMONY Big Data Platform
Connect with us at the EHA2021 Virtual Congress and learn about new HARMONY results
#Bigdataforbloodcancer Blog: Bringing together data, collaboration and trust for advances in medicine
#Bigdataforbloodcancer Blog: Artificial intelligence to decode Hematologic Malignancies
#Bigdataforbloodcancer Blog: Selecting the right treatment for the right patient: The HARMONY approach.
Towards curing pediatric ALL with less chemotherapy. HARMONY presenting at CCI Europe Conference 2021/SIOPE annual meeting.
HARMONY invites bone marrow transplant professionals to become involved
#BigDataforBloodCancer: Become involved in the HARMONY Alliance!
HARMONY Alliance sessions at the European LeukemiaNet Meeting
Joining forces to improve the treatment of myeloma: HARMONY participating in the second European Myeloma Network Meeting
HARMONY Alliance develops Core Outcome Sets for blood cancers. About Delphi Surveys.
End of year message
PRESS RELEASE: New data from HARMONY demonstrate the power of Big Data analytics to inform personalized medicine in blood cancer
HARMONY presents new results at the virtual 62nd Annual Meeting of the American Society of Hematology
HARMONY study maps uncertainties in clinical evidence that may impact market access for novel drugs in Hematologic Malignancies
Press Release: The HARMONY Alliance launches HARMONY PLUS, a new public-private partnership to improve outcomes for patients with blood cancers
IMI showcases HARMONY’s efforts in managing COVID-19
HARMONY-EHA webinar: The power of integrating harmonized AML patient data in hematology research
HARMONY Launched NHL Delphi Survey to Develop a Core Outcome Set for Non-Hodgkin Lymphoma
AML Hub interviews Professor Lars Bullinger, leader of HARMONY Work Package Definitions of Outcomes
1-24   25-48   49-72   73-96   97-120   121-144   145-168   169-192   193-216